Lucid Diligence Brief: Sun Pharma acquisition of Organon
Lucid Diligence Brief: Sun Pharma acquisition of Organon Professional audiences…
Lucid Diligence Brief: Transcenta x EirGenix HiCB licensing
Lucid Diligence Brief: Transcenta x EirGenix HiCB licensing Professional…
Respiratory Today—December 5, 2025
This week’s respiratory update highlights major developments across RSV…
Immunology Weekly News - September 17th 2025
🔬 This week in Immunology Updates: Immunology Licensing Deal, Phase II SKYWAY…
Neuroscience Weekly News - September 10th 2025
🧠 This Week in Neuroscience: PTSD Treatment, MS Stem Cell Therapy and More…
Immunology Weekly News - August 27th 2025
🔬 This week in Immunology Updates: A pivotal biosimilar launch, regulatory…
Endocrinology Weekly Update - July 8th 2025
🧬 Endocrinology Update: Acromegaly Heart Breakthrough, AI in Diabetes, New…
Immunology Weekly News - May 7th 2025
🧠 This Week in Immunology: FDA Approvals, Gene Therapy Breakthroughs &…
Immunology Weekly News - April 23rd 2025
🧬 Weekly Immunology Breakthroughs: Big Moves in Autoimmune, AI, and Allergy…
Immunology Weekly News - April 16th 2025
🧬 Weekly Immunology Breakthroughs: Adolescent Psoriasis, PsA Joint Protection,…
How Education can serve as a catalyst for wider Biosimilar Adoption.
Even two decades after their introduction, the global adoption rate of…
Navigating the Biosimilar Landscape: What to watch out in 2024 and Beyond
The anticipated expiration of exclusivity rights for major biologics in 2022…
